Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Activated oncogenes and anticancer chemotherapy induce cellular senescence, a terminal growth arrest of viable cells characterized by S-phase entry-blocking histone 3 lysine 9 trimethylation (H3K9me3). Although therapy-induced senescence (TIS) improves long-term outcomes, potentially harmful properties of senescent tumour cells make their quantitative elimination a therapeutic priority. Here we use the Eµ-myc transgenic mouse lymphoma model in which TIS depends on the H3K9 histone methyltransferase Suv39h1 to show the mechanism and therapeutic exploitation of senescence-related metabolic reprogramming in vitro and in vivo. After senescence-inducing chemotherapy, TIS-competent lymphomas but not TIS-incompetent Suv39h1(-) lymphomas show increased glucose utilization and much higher ATP production. We demonstrate that this is linked to massive proteotoxic stress, which is a consequence of the senescence-associated secretory phenotype (SASP) described previously. SASP-producing TIS cells exhibited endoplasmic reticulum stress, an unfolded protein response (UPR), and increased ubiquitination, thereby targeting toxic proteins for autophagy in an acutely energy-consuming fashion. Accordingly, TIS lymphomas, unlike senescence models that lack a strong SASP response, were more sensitive to blocking glucose utilization or autophagy, which led to their selective elimination through caspase-12- and caspase-3-mediated endoplasmic-reticulum-related apoptosis. Consequently, pharmacological…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another approach is based on the high lysosomal activity of some senescent cells that renders them sensitive to lysosomal ATPase inhibitors94.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [94]
In the citing paper
“In preclinical models, proteotoxic stress not only drives entry into a senescent state, but also activates autophagy, which consequently buffers toxicity from misfolded SASP factors 44,45 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“These findings suggest that mTOR inhibitors, commonly referred to as rapalogs, might induce or prevent senescence in a context- dependent manner 45,48,49 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“Multiple factors involved in senescence induction, such as oxidative stress and proteotoxic stress, lead to protein misfolding, which in turn evokes endoplasmic reticulum stress via the unfolded protein response 45,53 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“Reconversion of lactate to pyruvate by l-lactate dehydrogenase B fuels the TCA cycle out of the senescence-enforced enhancement of non-oxidative glucose metabolism (commonly referred to as the Warburg effect) 45 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,256
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Gas chromatography mass spectrometry–based metabolite profiling in plants
Lisec, J., Schauer, N., Kopka, J., Willmitzer, L., & Fernie, A. R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.59 · Cited by 2,170
Self-citation
Cited by
Items 301–400 of 540
Berberich, B., Thriene, K., Gretzmeier, C., Kühl, T., Bayer, H., Athanasiou, I., Rafei-Shamsabadi, D. A., Bruckner‐Tuderman, L., Nyström, A., Kiritsi, D., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.02.040 · Cited by 28
Implications of endoplasmic reticulum stress and autophagy in aging and cardiovascular diseases
Ma, C., Liu, Y., & Fu, Z. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1413853 · Cited by 28
Raghavendra, A. S., Kettner, N. M., Kwiatkowski, D. N., Damodaran, S., Wang, Y., Ramirez, D. L., Gombos, D. S., Hunt, K. K., Shen, Y., Keyomarsi, K., et al. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00722-1 · Cited by 24
Bientinesi, E., Ristori, S., Lulli, M., & Monti, D. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111957 · Cited by 26
Mechanisms of cancer stem cell senescence: Current understanding and future perspectives
Zhang, D., Monteiro, M. J., Liu, J., & Gu, W. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13528 · Cited by 27
Modulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease
Pedroza-Díaz, J., Arroyave-Ospina, J. C., Salas, S. S., & Moshage, H. J. (2022) · Antioxidants · doi:10.3390/antiox11050975 · Cited by 32
“ER stress has been linked to senescence in different experimental models [148,149], e.”
MethodDelineating the heterogeneity of senescence-induced-functional alterations in hepatocytes
Kumar, P., Hassan, M., Tacke, F., & Engelmann, C. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05230-2 · Cited by 31
“Conversely, numerous studies reported that a high glycolysis rate, accompanied by elevated OXPHOS activity, was specific to oncogene-induced senescence [24, 39, 43].”
Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities
Zhang, J., Jinan, Z., & Chen, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06063-0 · Cited by 26
“2) [122, 123].”
Chan, A. M., Dziedziech, A., Kirkman, L. A., Deitsch, K., & Ankarklev, J. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02021-19 · Cited by 21
Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with Metformin
Yang, B., Damodaran, S., Khemees, T. A., Filon, M. J., Schultz, A., Gawdzik, J. C., Etheridge, T. J., Malin, D., Richards, K. A., Cryns, V. L., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-1141 · Cited by 22
“org Mol Cancer Ther; 19(11) November 2020 2279”
BackgroundInfluentialAutophagy and senescence, converging roles in pathophysiology as seen through mouse models
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2021.02.001 · Cited by 20
GRP78/BiP determines senescence evasion cell fate after cisplatin-based chemotherapy
Zin, Z., Choochuay, K., Tubsuwan, A., Pinkaew, D., Suksomtip, M., Vinayanuwattikun, C., Chanvorachote, P., & Chunhacha, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-01540-8 · Cited by 25
Therapeutic strategies targeting cellular senescence for cancer and other diseases
Wang, X., Fukumoto, T., & Noma, K.-I. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae015 · Cited by 29
“Senescent cells producing SASP factors tend to accumulate misfolded proteins, which are degraded by autophagy in an energy-consuming manner ( 80) .”
BackgroundMeiners, F., Hinz, B., Boeckmann, L., Secci, R., Sueto, S. O. B., Kuepfer, L., Fuellen, G., & Barrantes, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-55870-4 · Cited by 22
“active DNA damage responses (Ghosal & Chen, 2013), high metabolic activity including increased glycolysis (Dörr et al., 2013), and the reliance on dependence receptors to resist apoptosis (Goldschneider & Mehlen, 2010).”
BackgroundBrain macrophage senescence in glioma
Li, L., Zhang, T. C., Xiao, M., Lu, Y., & Gao, L. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.07.005 · Cited by 25
The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
Gomez-Casal, R., Bhattacharya, C., Epperly, M. W., Basse, P. H., Wang, H., Wang, X., Proia, D. A., Greenberger, J. S., Socinski, M. A., & Levina, V. V. (2015) · Cancers · doi:10.3390/cancers7020814 · Cited by 22
“Several signaling cascades are associated with the establishment of senescence phenotype: Classical pathways such as p53 which activates p21; and p16 that prevents phosphorylation of the retinoblastoma protein (Rb) [70,84–86].”
BackgroundVarela‐Nieto, I., Palmero, I., & Magariños, M. (2019) · Hearing Research · doi:10.1016/j.heares.2019.01.014 · Cited by 22
Wang, C., Tanizawa, H., Hill, C., Havas, A. P., Zhang, Q., Liao, L., Xue, H., Lei, X., Wang, L., Nie, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49745-5 · Cited by 23
“These results are consistent with the notion that metabolic needs and SASP are intimately linked 17 and the MTC may represent one layer of the integration between these two Fig.”
InfluentialJiang, X., Baig, A. H., Palazzo, G., Pizzo, R. D., Borteçen, T., Groessl, S., Zaal, E. A., Ramirez, C. C. A., Kowar, A., Huerta, D. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51901-w · Cited by 22
“This reprogramming is mediated by alterations in the activity of RNA-binding proteins and microRNAs, which control mRNA translation and stability and may lead to increased protein synthesis to support the altered cellular phenotype 20,21,46 .”
Role of chemokines in aging and age-related diseases
Chaudhary, J. K., Danga, A. K., Kumari, A., Bhardwaj, A., & Rath, P. C. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.112009 · Cited by 30
Breaking Cancer’s Momentum: CDK4/6 Inhibitors and the Promise of Combination Therapy
Liu, Y., Park, S., & Li, Y. (2025) · Cancers · doi:10.3390/cancers17121941 · Cited by 21
“And senescent lymphoma cells are more sensitive to glucose utilisation inhibition and autophagy inhibition compared to normal lymphoma cells [97].”
Wen, Z., Xia, G., Liang, C., Wang, X., Huang, J., Zhang, L., Shan, D., Song, W. C., & Cao, X. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0141 · Cited by 26
The role of cancer cell bioenergetics in dormancy and drug resistance
Tau, S. S., & Miller, T. W. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10081-7 · Cited by 26
“Another model of SASP in lymphoma cells displayed similar features where glycolysis inhibition was effective as a therapeutic strategy [51].”
BackgroundRadiopharmaceuticals as probes to characterize tumour tissue
Alam, I. S., Arshad, M., Nguyen, Q., & Aboagye, E. O. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2984-3 · Cited by 23
“found that therapyinduced senescence that is also characterized by expression of the S-phase entry-blocking histone-3 lysine-9 trimethylation mark is described as a negative change on F-FLT PET accompanied by a positive change on FFDG PET [110].”
BackgroundAziz, R. K., Monk, J. M., Lewis, R. M., Loh, S. I., Mishra, A., Nagle, A. A., Satyanarayana, C., Dhakshinamoorthy, S., Luche, M., Kitchen, D. B., et al. (2015) · Scientific Reports · doi:10.1038/srep16025 · Cited by 21
Proteomic characterisation of triple negative breast cancer cells following CDK4/6 inhibition
Beykou, M., Arias-García, M., Roumeliotis, T. I., Choudhary, J. S., Moser, N., Georgiou, P., & Bakal, C. (2022) · Scientific Data · doi:10.1038/s41597-022-01512-1 · Cited by 19
Cellular senescence in vivo: From cells to tissues to pathologies
Kumar, A., Bano, D., & Ehninger, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111308 · Cited by 20
Papaspyropoulos, A., Hazapis, O. G., Altulea, A., Polyzou, A., Verginis, P., Evangelou, K., Fousteri, M. I., Papantonis, A., Demaria, M., & Gorgoulis, V. G. (2023) · Aging Cell · doi:10.1111/acel.13893 · Cited by 18
Xiao, M., Chen, W., Wang, C., Wu, Y., Zhu, S., Zeng, C., Cai, Y., Liu, C., & He, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.23622 · Cited by 21
“Anti-cancer therapy can induce premature senility of primarily cultured cells or cancer cells, which is known as therapy-induced senescence (TIS) [26, 27].”
BackgroundGenotoxic Stress-Induced Senescence
Fan, D. N.-Y., & Schmitt, C. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_10 · Cited by 21
Self-citationSmyd3-PARP16 axis accelerates unfolded protein response and vascular aging
Yang, D., Wang, Q., Wei, G., Wu, J., Zhu, Y. C., Zhu, Q., Ni, T., Liu, X., & Zhu, Y. Z. (2020) · Aging · doi:10.18632/aging.103895 · Cited by 23
“senescence, whether the inducer is successive replications [33], oncogene activation [34, 35], DNAdamaging agents such as X-rays [36] or Adriamycin [35], or oxidative stress [37].”
BackgroundThe persistent dynamic secrets of senescence
Schmitt, C. A. (2016) · Nature Cell Biology · doi:10.1038/ncb3403 · Cited by 18
Self-citationCellular Senescence: A Bridge Between Diabetes and Microangiopathy
Liu, J., Guo, B., Liu, Q., Zhu, G., Wang, Y., Wang, N., Yang, Y., & Fu, S. (2024) · Biomolecules · doi:10.3390/biom14111361 · Cited by 23
“The inhibitory effect of autophagy delays OIS, which may include the acquisition of autophagy and its effects on the OIS phenomenon [92].”
Sobeai, H. M. A., Alohaydib, M. H., Alhoshani, A., Alhazzani, K., Almutairi, M. M., Saleh, T., Gewirtz, D. A., & Alotiabi, M. R. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.12.004 · Cited by 20
AKT but not MYC promotes reactive oxygen species-mediated cell death in oxidative culture
(2020) · doi:10.1242/jcs.239277 · Cited by 18
“As such, combinational therapies that generate synthetic lethality in tumors also need to be investigated in the context of oncogene dependence (Clark et al., 2012; Dörr et al., 2013; Joly et al., 2020; O’Neil et al., 2017).”
BackgroundThe role of glycometabolic plasticity in cancer
Peng, Y., Yang, H., & Li, S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153595 · Cited by 20
The Potential of Senescence as a Target for Developing Anticancer Therapy
Jo, H., Shim, K., & Jeoung, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043436 · Cited by 20
“The report on the one-two punch approach to selectively eliminate chemotherapy-induced senescent lymphoma cells in mice was achieved by using a metabolic senolytic to block glucose utilization or autophagy [164].”
BackgroundMethodCombination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier
Etheridge, T. J., Damodaran, S., Schultz, A., Richards, K. A., Gawdzik, J. C., Yang, B., Cryns, V. L., & Jarrard, D. F. (2018) · Asian journal of urology · doi:10.1016/j.ajur.2018.09.001 · Cited by 17
“Glycolysis AMPK inhibitor compound C [36]/AMPK activator and mTOR inhibitor”
BackgroundInfluentialMitochondria-driven elimination of cancer and senescent cells
Hubáčková, S., Novais, S. M., Davidová, E., Neužil, J., & Rohlena, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0256 · Cited by 20
Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 24
“Since senescent cells display heightened dependence on anti-apoptotic and stress-survival pathways 243 , senescence induction creates therapeutic windows for senolytic targeting 80,246,261,271-273 .”
InfluentialBioenergetics: the evolutionary basis of progressive kidney disease
Chevalier, R. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00029.2022 · Cited by 19
Unveiling the role of cellular dormancy in cancer progression and recurrence
Collignon, É. (2024) · Current Opinion in Oncology · doi:10.1097/cco.0000000000001013 · Cited by 16
Intracellular acidification and glycolysis modulate inflammatory pathway in senescent cells
Kawakami, S., Johmura, Y., & Nakanishi, M. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae032 · Cited by 16
“Increased glucose uptake and glycolysis is one of the major metabolic changes in senescent cells ( 13, 34, 35 ), but contribution of these metabolic changes to SASP remains unknown.”
BackgroundMalavolta, M., Pierpaoli, E., Giacconi, R., Basso, A., Cardelli, M., Piacenza, F., & Provinciali, M. (2018) · Biological Procedures Online · doi:10.1186/s12575-018-0087-4 · Cited by 22
“Moreover, γ-T3 have been shown to suppress aerobic glycolysis [57] which may be a key survival factor in some senescent cells [12].”
Ye, Z., Che, H.-B., Zhang, T.-Y., Chen, Z., Tian, L., & Gu, D.-N. (2020) · Oncology Letters · doi:10.3892/ol.2020.12400 · Cited by 21
“Cellular senescence, as a stress‐responsive cell cycle arrest program, is commonly considered as a tumor‐suppressing response (7) and has been demonstrated to contribute to the outcomes of anticancer chemotherapy in vivo, such as in lymphoma (8).”
BackgroundSenescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control
Belenki, D., Richter‐Pechańska, P., Shao, Z., Bhattacharya, A., Lau, A., de Freitas, J. A. N. L. F., Kandler, G., Hick, T., Cai, X., Scharnagl, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57429-x · Cited by 16
“Bcl2 and Hras V12 overexpression plasmids have been described 17,36,38,54 .”
Self-citationMontuori, G., Tu, F., Qin, D., Schmargon, R., Rodriguez-Fos, E., Helmsauer, K., Hui, H., Mandal, S., Purshouse, K., Fankhänel, L., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1738 · Cited by 15
Self-citationUsing mass spectrometry imaging to visualize age-related subcellular disruption
Hogan, K. A., Zeidler, J. D., Beasley, H. K., Alsaadi, A. I., Alshaheeb, A. A., Chang, Y., Tian, H., Hinton, A. O., Jr., & McReynolds, M. R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.906606 · Cited by 16
“, 2014), xenobiotics (Dörr et al., 2013; Williams et al., 2013; Matos et al., 2015), and DNA damage (Panganiban et al.”
BackgroundInfluentialCellular Senescence, a Novel Area of Investigation for Metastatic Diseases
Faggioli, F., Velarde, M. C., & Wiley, C. D. (2023) · Cells · doi:10.3390/cells12060860 · Cited by 16
Androgen Receptor Activation Induces Senescence in Thyroid Cancer Cells
Gupta, A., Carnazza, M. A., Jones, M., Darżynkiewicz, Z., Halicka, D. H., O'Connell, T. J., Zhao, H. L., Dadafarin, S., Shin, E. D., Schwarcz, M., et al. (2023) · Cancers · doi:10.3390/cancers15082198 · Cited by 18
Metabolic regulation of endothelial senescence
Le, N.-T. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1232681 · Cited by 16
The power and the promise of synthetic lethality for clinical application in cancer treatment
Liu, Q., Yang, Z., Tang, Q.-H., Wang, W.-E., Chu, D.-S., Ji, J.-F., Fan, Q.-Y., Jiang, H., Yang, Q.-X., Zhang, H., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116288 · Cited by 17
Cellular Senescence in Renal and Urinary Tract Disorders
Santin, Y., Lluel, P., Rischmann, P., Gamé, X., Mialet‐Perez, J., & Parini, A. (2020) · Cells · doi:10.3390/cells9112420 · Cited by 17
“For instance, the production of SASP components has been shown to rely on enhanced ATP production mediated by increased mitochondrial metabolism and glycolysis, but finally leading to a massive proteotoxic stress [12].”
BackgroundCellular senescence in neuroblastoma
Zanotti, S., Decaesteker, B., Vanhauwaert, S., Wilde, B. D., Vos, W. H. D., & Speleman, F. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01755-0 · Cited by 18
“Clearance of senescent cells Immune cells SASP SASP Therapy-induced senescence Anti-tumourigenic In d u ce rs D yn am ic im p ac t o n t u m o u r g ro w th Oxidative stress O O Telomere dysfunction Oncogene activation DNA damage Inflammation Senescent cell Proto-oncogene Cellular senescence a b c Pro-tumourigenic Cel…”
BackgroundInfluentialFeedback amplification of senolysis using caspase-3-cleavable peptide-doxorubicin conjugate and 2DG
Lee, J. C., Kim, G. C., Lee, N. K., Kim, S. W., Cho, Y. S., Chung, S. W., Lee, Y. J., Chang, H. W., Byun, Y., & Kim, S. Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.012 · Cited by 15
The Potent and Paradoxical Biology of Cellular Senescence in Cancer
Romesser, P. B., & Lowe, S. W. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-124434 · Cited by 16
Marmisolle, I., Chacón, E., Mansilla, S., Ruiz, S., Bresque, M., Martínez, J., Martínez‐Zamudio, R. I., Herbig, U., Liu, J., Finkel, T., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103606 · Cited by 16
Zhang, K., Chen, C., Liu, Y., Chen, H., & Liu, J. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12328 · Cited by 16
Du, J., Neuenschwander, M., Yu, Y., Däbritz, J. H. M., Neuendorff, N. R., Schleich, K., Bittner, A., Milanovic, M., Beuster, G., Radetzki, S., et al. (2016) · Blood · doi:10.1182/blood-2016-02-700773 · Cited by 14
“Relative transcripts levels were calculated based on the comparative DD cycle threshold method.(30) A list of TaqMan assays used is available in supplemental Table 2.”
MethodSelf-citationMitochondria in cell senescence: A Friend or Foe?
Chen, Q., Young, L. H., & Barsotti, R. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.019 · Cited by 15
Macroautophagy and the Oncogene-Induced Senescence
Grasso, D., & Vaccaro, M. I. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00157 · Cited by 13
“In recent years, the idea of a therapeuticinduced senescence as a potential cancer treatment has gained importance (30, 58, 59).”
Autophagy : Moving Benchside Promises to Patient Bedsides
Belaïd, A., Ndiaye, P. D., Filippakis, H., Roux, J., Röttinger, É., Graba, Y., Brest, P., Hofman, P. M., & Mograbi, B. (2015) · Current Cancer Drug Targets · doi:10.2174/156800961508151001102452 · Cited by 13
Epigenetic adaptations in drug-tolerant tumor cells
Mani, N., Daiya, A., Chowdhury, R., Mukherjee, S., & Chowdhury, S. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2022.12.006 · Cited by 15
MicroRNAs-associated with FOXO3 in cellular senescence and other stress responses
Khor, Y.-S., & Wong, P. (2023) · Biogerontology · doi:10.1007/s10522-023-10059-6 · Cited by 16
“Autophagy activation also occurs in response to proteotoxic stress caused by SASP factors as well as to support enhanced ATP requirement by increasing mitochondrial respiration (Dörr et al. 2013; Pérez-Mancera et al. 2014).”
Pulsed Stable Isotope-Resolved Metabolomic Studies of Cancer Cells
Pietzke, M., & Kempa, S. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801329-8.00009-x · Cited by 15
Self-citationRoy, S., Malone, S. C., Grimes, S., & Morgan, S. C. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.09.005 · Cited by 13
Jeong, D., Park, S. H., Kim, J., Kim, H., Jang, Y., Koh, J., Jeon, Y. K., Tasaki, T., Kwon, Y. T., Han, D., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2425015122 · Cited by 14
Filon, M. J., Gillette, A. A., Yang, B., Khemees, T. A., Skala, M. C., & Jarrard, D. F. (2022) · The Prostate · doi:10.1002/pros.24428 · Cited by 17
“To obtain an overview of metabolism during this time frame, MS was used to temporally measure changes in the metabolite profile of the hormone sensitive (LNCaP) cell line at 4 and 8 days after ADT.”
BackgroundInfluentialZhang, Y., Xiao, X., Yang, G., Jiang, X., Jiao, S., Nie, Y., & Zhang, T. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03770-6 · Cited by 15
“This phenotype is reinforced by upregulated glycolytic enzymes in senescent lymphoma and melanoma cells and oncogene-induced senescence cells (e.g., BRAF V600E ) [30, 31].”
Seno-suppressive molecules as new therapeutic perspectives in rheumatic diseases
Tachikart, Y., Malaise, O., Mumme, M., Jørgensen, C., & Brondello, J. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.017 · Cited by 12
TWIST1 controls cellular senescence and energy metabolism in mesenchymal stem cells
Voskamp, C., Anderson, L. A., Koevoet, W., Barnhoorn, S., Mastroberardino, P. G., van Osch, G. J. V. M., & Narcisi, R. (2021) · European Cells and Materials · doi:10.22203/ecm.v042a25 · Cited by 12
Cellular senescence implication in mustard keratopathy
Soleimani, M., Baharnoori, S. M., Cheraqpour, K., Momenaei, B., Mirshahi, R., Chow, C., Shahjahan, S., Nguyen, T., Ashraf, M. J., Huang, X., et al. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109565 · Cited by 13
Cellular senescence and tumor promotion: Role of the Unfolded Protein Response
Pluquet, O., & Abbadie, C. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.001 · Cited by 13
Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing
Garana, B. B., Joly, J. H., Delfarah, A., Hong, H., & Graham, N. A. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05343-8 · Cited by 12
“Both senescence-inducing and senolytic compounds have great 594 therapeutic promise in aging [52–56], cancer [57, 58], and other diseases [59].”
BackgroundMulti-assay assessment of cytotoxicity reveals multiple mechanisms of action in 3D microtissues
Zein-Sabatto, A., Angelo, K. S., Madnick, S. J., Hoffman–Kim, D., Morgan, J. R., & Lee, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-86792-4 · Cited by 12
Impacts of ageing on the efficacy of CAR-T cell therapy
Qi, S., Li, J., Gu, X., Zhang, Y., Zhou, W., Wang, F., & Wang, W. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102715 · Cited by 13
Detecting Markers of Therapy-Induced Senescence in Cancer Cells
Fan, D. N.-Y., & Schmitt, C. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_4 · Cited by 14
Self-citationRothmiller, S., Jäger, N., Meier, N., Meyer, T., Neu, A., Steinritz, D., Thiermann, H., Scherer, M. A., Rummel, C., Mangerich, A., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02946-5 · Cited by 12
“Etomoxir and antimycin A target differences between senescent and non-senescent cells in cell metabolism (Dörr et al. 2013); dasatinib and quercetin are kinase inhibitors (Zhu et al.”
BackgroundKang, T., Moore, E. C., Kopania, E. E. K., King, C. D., Schilling, B., Campisi, J., Good, J. M., & Brem, R. B. (2023) · G3: Genes, Genomes, Genetics · doi:10.1093/g3journal/jkad091 · Cited by 10
“would follow from current models of the senescent state in which production and secretion of 593 SASP components (96) leads to proteotoxic stress from insoluble aggregates (45,46), an 594”
BackgroundAbdelmoaty, A. A. A., Chen, J., Zhang, K., Wu, C., Li, Y., Li, P., & Xu, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1422363 · Cited by 11
The PARP inhibitor olaparib promotes senescence in murine macrophages
Kieronska‐Rudek, A., Zuhra, K., Ascenção, K., Chłopicki, S., & Szabó, C. (2025) · GeroScience · doi:10.1007/s11357-025-01679-6 · Cited by 15
Phosphoinositide species and filamentous actin formation mediate engulfment by senescent tumor cells
Frey, W. D., Anderson, A. Y., Lee, H., Nguyen, J. B., Cowles, E., Lu, H., & Jackson, J. G. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001858 · Cited by 11
Autophagy-dependent regulation of tumor metastasis by myeloid cells
Jinushi, M., Morita, T., Xu, Z., Kinoshita, I., Dosaka‐Akita, H., Yagita∥, H., & Kawakami, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179357 · Cited by 14
UnSASPing Senescence: Unmasking Tumor Suppression?
Schmitt, C. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.009 · Cited by 11
Self-citationTherapy-Induced Tumor Cell Senescence: Mechanisms and Circumvention
Zamkova, M. A., Александровна, П. Н., Tatarskiy, V. V., & Shtil, A. A. (2023) · Biochemistry (Moscow) · doi:10.1134/s000629792301008x · Cited by 10
Xie, J., Guo, Y., Fan, S.-H., Zheng, Y., Zhang, H., Zhang, Y., Zhang, Y., & Lin, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137991 · Cited by 12
A lncRNA-mediated metabolic rewiring of cell senescence
Grossi, E., Marchese, F. P., González, J., Goñi, E., Fernández-Justel, J. M., Amadoz, A., Herranz, N., Puchades‐Carrasco, L., Montes, M., & Huarte, M. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115747 · Cited by 13
Liu, W., Fan, B., Fang, T., Li, H., Zhang, J., Liu, B., & Liu, Z. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.010 · Cited by 10
“In 2013, the first demonstration of selective pharmacological elimination of senescent cells by synthetic lethal metabolic pathways was reported 30 .”
Mikawa, T., Kameda, M., Ikari, S., Shibata, E., Liu, S., Miyagawa, S., Ono, K., Ito, T., Yoshizawa, A., Sugimoto, M., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02502-6 · Cited by 15
“20 However, careful design is needed to target glycolysis as a therapeutic approach, as glycolysis, a vital metabolic pathway, is also augmented in rapidly proliferating standard cells.”
Hu, X., Guo, L., Liu, G., Dai, Z., Wang, L., Zhang, J., & Wang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.997702 · Cited by 10
“Recent studies have also identified that various processes, including oncogene activation (10–12), radiation (13, 14), chemotherapy (15, 16), and mitochondrial dysfunction (17, 18), were associated with the development and progression of cellular senescence.”
BackgroundMitochondria–endoplasmic reticulum contact sites in hepatocytic senescence
Kumar, P., Hassan, M., Tacke, F., & Engelmann, C. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00809-4 · Cited by 10
“In another MERC partner, ER, chronic stress is a recognized contributor to senescence across various models [124–126].”
Autophagy modulation in cancer
Guilbaud, E., Ryan, K. M., Green, D. R., & Galluzzi, L. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01449-9 · Cited by 15
“…linked to the persistence of senescent cancer cells (which foster disease progression via their secretome), via multiple mechanisms including the preservation of ribosome homeostasis and alternative splicing events 157–161 , and to favour DNA repair upon exposure to genotoxic agents 78,162–168 .”
Recent Advancement in Elimination Strategies and Potential Rejuvenation Targets of Senescence
Kureel, S. K., Blair, B., & Sheetz, M. P. (2023) · Advanced Biology · doi:10.1002/adbi.202300461 · Cited by 10
Chemotherapy-induced cellular senescence suppresses progression of Notch-driven T-ALL
Zhang, Y., Gundelach, J. H., Lindquist, L. D., Baker, D. J., van Deursen, J., & Bram, R. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224172 · Cited by 9
Lee, Y. Y., Choi, Y. S., Kim, D. W., Cheong, J. Y., Song, K. Y., Ryu, M. S., & Lim, I. K. (2020) · Aging · doi:10.18632/aging.103029 · Cited by 9
“However, mitochondrial oxidative metabolism is upregulated in senescent cells as a metabolic requirement [8, 9].”
Identification of a Proteomic Signature of Senescence in Primary Human Mammary Epithelial Cells
Delfarah, A., Hartel, N. G., Zheng, D., Yang, J., & Graham, N. A. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00659 · Cited by 8
Centrosome-phagy: implications for human diseases
Wu, Q., Yu, X., Liu, L., Sun, S., & Sun, S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00557-w · Cited by 10
“A few studies have demonstrated that suppression of mitophagy is exhibited in senescent cells and leads to a defective mitochondrial network that might result in metabolic dysfunction during aging [81, 82].”
BackgroundBianchi, A., Lipchick, B. C., & Nikiforov, M. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_1 · Cited by 10
Monterrubio-Ledezma, F., Salcido-Gómez, A., Zavaleta-Vásquez, T. I., Navarro‐García, F., Cisneros, B., & Massieu, L. (2025) · GeroScience · doi:10.1007/s11357-024-01501-9 · Cited by 7
The Interplay of Aging and Cancer: Mechanisms, Implications, and Therapeutic Strategies
Wang, L., Luo, Y., Chen, X., Wang, Y., & Zhang, Y. (2025) · MedComm – Oncology · doi:10.1002/mog2.70041 · Cited by 10
Metadata
- Authors
- Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., Kratzat, S., Purfürst, B., Walenta, S., Mueller-Klieser, W., Gräler, M., Hummel, M., Keller, U., Buck, A. K., Dörken, B., Willmitzer, L., Reimann, M., Kempa, S., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Max Delbrück Center (DE)
- German Cancer Research Center (DE)
- Technical University of Munich (DE)
- Johannes Gutenberg University Mainz (DE)
- Jena University Hospital (DE)
- Universitätsklinikum Würzburg (DE)
- Max Planck Institute of Molecular Plant Physiology (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2013-08-14
- Volume
- 501
- Issue
- 7467
- Pages
- 421-425
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1987142903
- Cited by
- 541
- References
- 46
- Citations by year
- 2026: 24 · 2025: 35 · 2024: 42 · 2023: 42 · 2022: 40 · 2021: 55 · 2020: 57 · 2019: 35 · 2018: 45 · 2017: 37 · 2016: 43 · 2015: 41 · 2014: 44 · 2013: 1
- FWCI
- 29.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, therapy-induced senescence, synthetic lethality, metabolic targeting, glucose metabolism, autophagy inhibition, senescence-associated secretory phenotype, proteotoxic stress, endoplasmic reticulum stress, unfolded protein response, SUV39H1, H3K9 methylation, Eμ-Myc lymphoma, chemotherapy-induced senescence
- MeSH terms
- Animals, Autophagy, Disease Models, Animal, Female, Glucose, Male, Mice, Transgenic, Stress, Physiological, Survival Rate, Lymphoma, B-Cell, Cellular Senescence, Apoptosis, Mice, Caspase 3, Caspase 12, Proteolysis, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.